新余国科 reported revenue of ¥0.16B for the period ended 2026-06-30, -4.3% year on year. Net income was ¥0.02B, a 11.2% net margin on a 40.2% gross margin. The largest revenue line is 军品 at 57% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.16B | -4.3% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | -33.5% |
| Gross margin | 40.2% | Net margin 11.2% |
| Revenue Q/Q | +90.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 军品 | ¥0.09B | 56.6% |
| 民品 | ¥0.06B | 39.5% |
| 其他业务 | ¥0.01B | 3.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 59.8% |
| R&D | ¥0.02B | 12.5% |
| SG&A | ¥0.03B | 17.9% |
| Tax & other | ¥0.00B | 1.2% |
| Item | Amount |
|---|---|
| Total assets | ¥0.91B |
| Total liabilities | ¥0.26B |
| Shareholders' equity | ¥0.64B |
| Equity / assets | 70.7% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | -170% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
一品红 ・ 捷佳伟创 ・ 药石科技 ・ 宏达电子 ・ 润禾材料 ・ 乐歌股份 ・ 科创信息 ・ 科创新源 ・ 设研院 ・ 西菱动力 ・ 光弘科技 ・ 百邦科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies